With high costs of therapeutic development, success relies on optimising preclinical and early clinical studies.
Download this content-rich digital article to read about considerations for implementing and standardising high-dimensional immune profiling methods into drug development programs. Learn about different applications that demonstrate the robustness and reproducibility of a mass cytometry-based analysis to deeply interrogate complex biological systems in drug development strategies, including:
- Rigorous testing of promising drug targets for safety and efficacy
- Correlates of survival prediction to support new treatment strategies
- Using systems biology for thorough target evaluation
- Enabling comprehensive and quantitative analysis in all phases of drug development
